American Shared Hospital Services (AMS) NPV

Sell:$2.01Buy:$2.81$0.07 (2.48%)

Prices delayed by at least 15 minutes
Sell:$2.01
Buy:$2.81
Change:$0.07 (2.48%)
Prices delayed by at least 15 minutes
Sell:$2.01
Buy:$2.81
Change:$0.07 (2.48%)
Prices delayed by at least 15 minutes

Company Information

About this company

American Shared Hospital Services is a provider of turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). It can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The Company provides radiation therapy services both domestically and internationally.

Key people

Raymond C. Stachowiak
Executive Chairman of the Board
Craig Kenji Tagawa
President, Assistant Secretary
Gary Delanois
Chief Executive Officer
R. Scott Frech
Chief Financial Officer
Ranjit Pradhan
Senior Vice President - Sales and Marketing
Alexis N Wallace
Corporate Secretary
Daniel G. Kelly
Lead Independent Director
Kathleen Miles
Independent Director
Vicki L. Wilson
Independent Director
Click to see more

Key facts

  • EPIC
    AMS
  • Location
    United States
  • Sector
    Services
  • Industry
    Rental & Leasing
  • ISIN
    US0295951059
  • Market cap
    $17.87m
  • Employees
    81
  • Shares in issue
    6.45m
  • Exchange
    Nyse American LLC
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.